“The Effectiveness of Platelet-Rich Plasma Therapy for Knee Osteoarthritis”
Knee osteoarthritis is a common joint disorder that causes pain and disability. Platelet-rich plasma (PRP) therapy has emerged as a potential treatment option, but its efficacy remains controversial.
A randomized controlled trial was conducted to evaluate the effectiveness of PRP therapy for knee osteoarthritis. Fifty patients with knee osteoarthritis were randomly assigned to receive either PRP therapy or a placebo. Pain and function were evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) at baseline, 3 months, and 6 months.
At 3 months, patients who received PRP therapy had significantly lower WOMAC scores for pain and function compared to the placebo group (p < 0.05). These benefits were maintained at 6 months. No adverse events were reported.
This study provides evidence that PRP therapy is effective in reducing pain and improving function in patients with knee osteoarthritis. These findings suggest that PRP therapy may be a promising treatment option for this condition. Further research is needed to determine the optimal dosing and duration of treatment.